Antisense oligos complementary to the 5-end, but not to the 3-end, of the estrogen receptor (ER) messenger RNA caused a paradox accumulation of ER protein in MCF-7 cells. The same effect was observed after treatment of the cells with the corresponding sense oligos. The oligos interfering with ER down-regulation were demonstrated to specifically bind the ER with affinities in the nanomolar range. It is, therefore, proposed that the ER up-regulation induced by the oligos might be due to squelching of the ER (or ER-inducible proteins) from their binding site located in the 5-end of the ER gene. We also report that transcriptionally inactive ER mutants can undergo down-regulation, and that in denaturing gels, the migration profile of ER-oligo and ER-estrogen-responsive element complexes are dissimilar. We, therefore, propose that ER can interact with DNA in different ways and at different binding sites. These observations might have important pharmacological consequences, since specific drugs could be devised to induce the ER conformation necessary to perform only selected tasks of the ER transcriptional repertoire. (Molecular Endocrinology 11: 938-949, 1997)
INTRODUCTION
17␤-Estradiol (E 2 ) exerts its physiological effects on target tissues by interacting with its cognate estrogen receptor (ER), which is a member of a superfamily of ligand-regulated transcription factors (1) (2) (3) . Several lines of evidence prove that after steroid binding, the hormone-receptor complex interacts with specific DNA target sequences, named estrogen-responsive elements (ERE), which are located in the promoter of estrogen-responsive genes (4) (5) (6) . The activity of the hormone-receptor complex can then be further modulated by a series of proteins acting as coactivators or as repressors (7) (8) (9) (10) .
The concentration of ER is an important determinant of cellular responsiveness to steroids, as suggested by the observation that in mammals, ER expression fluctuates in a spatial-temporal fashion in response to a variety of endocrine stimuli. Further support for this view is provided by studies at the cellular level, demonstrating that receptor expression above a specific concentration threshold is required for ER-mediated events to occur (11, 12) .
Due to the involvement of estrogens in an increasing number of pathologies (13, 14) , the study of receptor regulation may have relevant pharmacological and therapeutical consequences. To date, a limited number of studies have addressed the mechanisms of ER regulation, which remain elusive. It is known that ER intracellular content may be regulated by selected hormonal signals (e.g. the heterologous down-regulation induced by progesterone) (15) . In the majority of animal cells and tissues studied, the ER concentration is under a control primarily exerted by estrogens through a process termed autologous down-regulation or autologous up-regulation depending on the tissue being considered (16) (17) (18) . The experimental evidence obtained to date seems to indicate that in cells of cancer origin, the activated ER is an integral part of this regulatory process. Saceda et al. (19) showed that at least part of the autologous down-regulation is associated with a decrease in the cell content of ER messenger RNA (mRNA); this, in turn, results from a decreased ER gene transcription rate in a process that is cycloheximide resistant and hormone concentration dependent. The model devised to explain these findings invokes an interaction of the ER with its own gene, similar to the mechanism by which this same transcription factor regulates any other target gene (20, 21) . The activated ER, therefore, would bind selected regions in the pro-moter of its own gene, preventing its further transcription. The promoter of the ER gene, however, lacks the canonical ERE; this suggests that a novel mechanism of ER-DNA interaction may be involved.
To study the effect of estrogen on ER turnover, we used antisense oligonucleotides (aODN) (22, 23) as specific blockers of ER mRNA translation (24) (25) (26) . It is well known that many variables are involved in the mechanism of action of aODN, and systematic studies on these variables in eukaryotic systems are still lacking; it is, then, difficult to predict the best targets for aODN. To select the most active oligos, a series of molecules was synthesized and tested in a cell line expressing ER (MCF-7 cells). Contrary to our expectations, none of the antisense oligonucleotides used was able to block ER synthesis, whereas two of them caused a significant increase in the ER protein content. In addition, ER up-regulation was observed with oligos complementary (sense) to the aODNs tested.
These results indicated that the physiological machinery responsible for maintaining the intracellular ER levels could be offset by the presence of selected DNA sequences. This prompted us to further investigate the mechanisms underlying ER up-regulation mediated by aODNs.
RESULTS

Selected Sense and Antisense Oligonucleotides Increase ER Protein Content in MCF-7 Cells
Four antisense molecules corresponding to translated and untranslated 5Ј regions of the ER mRNA (Fig. 1A) and their complementary counterparts (sense) were tested in MCF-7 cells. The sequences selected for the initial studies were as follows: oligo1 (nucleotides Ϫ117/Ϫ99), GAC ATG CGC TGC GTC GCC; oligo2 (nucleotides 495/512), GCC AGT ACC AAT GAC AAG; oligo3 (nucleotides 1140/1157), TGT GCC TGG CTA GAG ATC; and oligo4 (nucleotides 4134/4151), GGG TCA GTG GGT TCT TTT. Care was taken to avoid homologies between the chosen sequences and other mRNAs deposited in EMBL and GenBank databases (with special attention to the mRNAs of the receptor superfamily members).
Fig. 1. Effects of Antisense and Sense Oligonucleotides on ER Protein Content in MCF-7 Cells
A, ER cDNA target sequences: oligo1 (nucleotides Ϫ117/Ϫ99), GAC ATG CGC TGC GTC GCC; oligo2 (nucleotides 495/512), GCC AGT ACC AAT GAC AAG; oligo3 (nucleotides 1140/1157), TGT GCC TGG CTA GAG ATC; and oligo4 (nucleotides 4134/4151), GGG TCA GTG GGT TCT TTT. B, Left, ER content was measured by EIA in extracts of MCF-7 cells treated for 48 h with 1 nM E 2 in the absence or presence of each of the oligos listed in A (14 M, final concentration). The bars represent the mean Ϯ SEM of a minimum of eight independent experiments performed in duplicate. *, P Ͻ 0.05; **, P Ͻ 0.01 (vs. controls, by ANOVA followed by Fisher's test). B, Right, Oligo2-induced ER up-regulation as assessed by Western blotting. MCF-7 cells were treated for 48 h with either 10 nM E 2 or 14 M ss oligo2 . Three hundred micrograms of whole cell extracts were immunoprecipitated and then run on SDS-PAGE (10% T) and analyzed by Western blotting using the anti-human ER antibody H 222 . Arrows indicate the position of the 67-kDa ER polypeptide as well as that of the heavy (H) and light (L) chains of IgG from the immunoprecipitation step. The autoradiograph shows results representative of three separate experiments.
The activity of the oligos on ER synthesis was determined by enzyme immunoassay (EIA) quantitation of ER protein content in cell lysates after 48-h treatment with 14 M oligonucleotides. Figure 1B , left, shows that in MCF-7 treated with oligo1 and oligo2 (both sense and antisense), the ER content was 73-107% higher than that in untreated control cells. Oligo3 and oligo4 did not modify the ER concentration with respect to that in controls.
Western blot analysis using the H 222 antibody as a probe (Fig. 1B, right) confirmed the increase in ER protein in MCF-7. Forty-eight hours after oligo2 treatment (right lane), the intensity of the specific 67-kDa ER band (arrow) was 50-70% higher than that in controls (left lane). After exposure to E 2 (middle lane), its intensity was 30-40% lower than that in controls. As the same amount of protein was subjected to immunoprecipitation, the strongly reactive IgG bands (arrows) may be regarded as loading and blotting controls. A number of bands, of lower M r , were detected in control and treated cell lysates. These may correspond to either cross-reacting components or intermediates in endocellular ER catabolism. The slight discrepancy in the extent of up-regulation, as quantitated by EIA or by densitometric scanning of Western blots, was attributed to both the different sensitivities of the two techniques and to the fact that the densitometric analysis had been restricted to the 67-kDa band.
To explain the ER intracellular accumulation caused by oligo1 and 2, we ruled out the hypothesis that this could occur via an interaction of the active oligos with the ER mRNA, reasoning that both sense and antisense had the same effect; therefore, a direct pairing with the mRNA sequence could not have occurred. An alternative explanation was provided by recent reports which postulated that intracellular receptors can control the transcriptional activity of their own genes by interacting with negative hormone-responsive elements located in the promoter or within the genecoding sequence (20) . If this were the case, the paradox effect observed with the oligonucleotides could have been due to the squelching of ER from the promoter of its own gene.
The observation that oligos promoting ER accumulation blocked E 2 -induced down-regulation, whereas the inactive oligos did not have any influence on the autologous down-regulation event (as shown in Fig. 2 ), further indicated that the oligos hindered the physiological mechanisms of ER autologous down-regulation.
Regardless of the represented strand (sense or antisense), only oligos corresponding to the 5Ј-region of the ER complementary DNA (cDNA) were found to up-regulate ER. Thus, it was conceivable that this region was primarily involved in ER autologous downregulation. To test this possibility, we studied E 2 -induced down-regulation in cells transiently transfected with mutants of the mouse ER cDNA. COS-1 cells were, therefore, transfected with the full-length mouse cDNA (MOR 1-599), an in-frame deletion mutant of the mouse ER cDNA lacking the activation domain AF-1 (MOR 182-599) and the DNA-binding domain mutant C241A/C244A, which is transcriptionally inactive (27) but, in our hands, binds DNA. As expected, E 2 induced decreases in ER mRNA (Ϫ56%; Fig. 3B ) and protein (Ϫ42%; Fig. 3A ) when the full-length ER cDNA was transfected. However, with the ER mutant lacking the NH 2 -terminus region (MOR 182-599), E 2 did not affect ER synthesis. This observation further underscored the hypothesis of a role in ER down-regulation of the cDNA sequences encoding residues 1-182 of the receptor.
Interestingly, E 2 induced down-regulation of the transcriptionally inactive ER mutant C241A/C244A of the DNA-binding domain, and this effect was of the same magnitude as that seen with the wild type receptor.
To further investigate the mechanism of aODN-dependent up-regulation, a series of experiments was undertaken with the most active of the oligos tested, oligo2. 
Gel Mobility Assay Argues for a Direct Interaction between ER and Oligo2
We first assessed by electrophoretic gel shift assay (EMSA) whether a direct interaction between oligo2 and ER protein could occur. The oligo2 retardation on gel, induced by ER, was compared with that of the canonical target for ER, the ERE. All of the studies were performed using MCF-7 nuclear extracts as the source of ER.
With oligo2 ( Fig. 4 ; A, antisense; B, sense; C, double strand), we observed several retarded bands; only one of these was competed off by cold oligo2 (arrow). When other oligos, such as those previously shown not to interfere with ER accumulation (e.g. oligo4) or scrambled oligos, were used, none of the retarded bands could be competed off (data not shown). We, therefore, concluded that the binding between ER and oligo2 (sense and antisense) was specific.
The binding affinities of ER for single (ss) and double (ds) stranded oligo2 were evaluated by saturation analysis, as described in Materials and Methods. The data in Fig. 4 were obtained by plotting the integrated areas from the densitometric scanning of the relevant bands according to Ligand (28) . The ds oligo2 bound ER with higher affinity than the ss oligo2 (ds oligo2 : K d ϭ 42 nM; sense oligo2 : K d ϭ 139 nM; antisense oligo2 : K d ϭ 423 nM). In all cases, however, the K d values for oligo2-ER interaction were significantly lower than those for ds ERE -ER (1.6 nM; Fig. 4D ).
To prove that the shifts of 32 P-labeled oligo observed were indeed due to the binding to ER, we checked whether the band corresponding to the oligo-receptor complex was supershifted in the presence of the specific anti-ER H 222 antibody. As shown in Fig. 5 , with both ds oligo2 and sense oligo2 the antibody caused a supershift of the complex comparable to that observed with ER-ERE. With antisense oligo2 we observed a smear of the retarded band, probably due to low affinity within the ERantisense oligo2 complex. The inactive oligo, oligo5, was not shifted in the presence of ER. To further prove that ER was responsible for the supershift reported above, we also tested nuclear extract from COS-1 cells, transfected or not with ER cDNA. No retarded band could be observed with extracts of COS-1 cells not expressing ER (see Fig. 8 ).
Fig. 3. Effects of ER Deletions on the Autologous Down-Regulation of ER mRNA and ER Protein
COS cells were transfected with 0.5 g/ml of plasmids containing either the wild type ER cDNA (MOR 1-599) or two mutated forms, MOR 182-599 and MOR C241A/C244A. After treatment of the cells with 1 nM E 2 for 48 h, the ER protein and ER mRNA levels were measured as described in Materials and Methods. A, Left, Representative immunoblot developed with the anti-ER H 222 antibody. The M r of the stained bands are 67 kDa for 1-599 and C241A/C244A, and 47 kDa for 182-599. A, Right, Densitometric analysis of ER protein levels after normalizing the data for ␤gal activity. B, Left, Agarose gel of the ER-RT PCR amplified DNA stained with ethidium bromide. The M r marker is HaeIII-cut pBR322 DNA. The size of the amplification products is 600 bp for GAPDH and 218 bp for ER. B, Right, Densitometric analysis of the amplified product levels after normalization with the GAPDH, which was used as an internal control. Data are expressed as the mean Ϯ SEM of three separate experiments. *, P Ͻ 0.01 vs. controls, by ANOVA followed by Fisher's test. 
Estrogens Do not Repress Transcription of the p-oligo2-GL2B-Luciferase Reporter Gene
To assess whether the interaction between ER and oligo2 resulted in transcriptional modulation, the oligo2 sequence was cloned in the promoterless luciferase vector pGL2B, which was analyzed in the ERnegative HeLa cells by cotransactivation assay with or without cotransfected ER. Figure 6 shows that with the empty pGL2B promoter, in the presence of E 2 -activated ER, the luciferase activity (LUC) was very low and not significantly higher than that in cells not expressing ER. The promoter containing oligo2 had over 2-fold higher basal transcription activity, and the presence of the unliganded receptor doubled LUC. The increased LUC due to ER presence, however, could not be modulated by E 2 (at high concentration, 100 nM). Similar results were obtained with transfection of empty or oligo2-containing pGL2B in MCF-7 cells (data not shown). In these ER-expressing cells the accumulation of LUC was almost 5-fold higher in oligo2-pGL2B-than in pGL2B-transfected cells. Also in this case, the presence of 100 nM E 2 did not cause any further accumulation of the reporter protein.
These results suggest that ER may bind oligo2, causing increased transcription of its downstream genes; this interaction, however, differs from the ER-ERE interaction, which is characteristically sensitive to the presence of the hormone (Fig. 6, right panel) . It is worth stressing that these findings do not comply with the view of oligo2 representing a negative response element.
Oligo2-ER Complex Migration across a Transverse Urea Gradient
The experiments described above proved the specific interaction of both ss-and ds oligo2 with ER. We further compared the characteristics of oligo2-ER and ERE-ER interaction by investigating the electrophoretic behaviors of these complexes under denaturing conditions.
The migration across a transverse urea gradient, as introduced by Creighton (29) correlates the unfolding of a protein molecule to a reduction in its electrophoretic mobility. The typical transition from the high to the low mobility form occurs over a defined interval of the chaotrope concentration, and the overall curve displays a sigmoidal shape. This technique may be applied to the study of interacting systems; different Equal amounts of MCF-7 nuclear extracts were tested in a supershift assay using DNA probes consisting of 32 P-labeled ds ERE , ds oligo2 , ss sense2 , ss antisense2 , and ds oligo5 in the absence (Ϫ) or presence (ϩ) of monoclonal antibody H 222 .
Fig. 6. Effect of Transient Transfection of ER on the Transcription of a Promoter Driven by Oligo2 or ERE
HeLa cells were transfected with the ER expression vector (1 g) or mock plasmid together with either pGL2B plasmid or the same plasmid containing the oligo2 sequence (1.5 g). As a control for transcription efficiency, all samples were cotransfected with 0.5 g pCMV-␤gal. Assays of luciferase and ␤gal were performed as described in Materials and Methods 48 h after addition of the hormone (100 nM E 2 ). All transfections were performed in triplicate. Bars represent the mean Ϯ SEM of two separate experiments.
profiles of migration are observed depending upon the homo-or heteromultimeric nature of the complex (30). We, therefore, ran a series of experiments aimed at studying the behavior under denaturing conditions of the ss-and ds oligo2 as well as ds ERE once complexed with ER.
Panels A-C in Fig. 7 compare the profiles of migration across increasing urea concentrations of ERds ERE and the complexes between ss-and ds oligo2 with ER. The end of the radioactive tracing corresponds to the urea concentration at which 32 Further examination of the dissociation/denaturation curves of the three forms of ER-oligo2 complex shows a migration profile parallel to the application trench (Fig. 7, A-C, bottom) . This implies that receptor-DNA dissociation occurs before any appreciable unfolding of the molecule. On the contrary, the migration of the ER-[
32 P]ds ERE complex slows down around 0.5 M urea (A-C, top), indicating that some unfolding occurs (presumably outside the receptor domain binding [
32 P]ds ERE ) before the complex dissociates. The unfolding of the ER molecule is thus likely to occur stepwise. Under the selected experimental conditions, however, we cannot actually monitor the behavior of ER, but can do so for the DNA-ER complex, although only up to the point of its dissociation.
In the unfolding assay the various domains within the ER molecule appear to behave independently. These data, therefore, support the view that [
32 P]ds ERE and oligo2 interact differently with the ER molecule. Moreover, the various domains appear to be differentially stabilized by the binding of their ligands. Examples of both features (ligand stabilization and stepwise unfolding) have been previously described for model systems (30) (31) (32) (33) (34) . Both the effective urea concentrations and the peculiar shapes of the dissociation/denaturation curves were evaluated in independent replicas of each run, and the behavior of each form of oligo2 was compared with that of ER-ds ERE in experiments (middle section of A-C) in which the reference and the test complexes were migrated in the same gel from two parallel trenches.
Evaluation of the Size of the ER [ 32 P]ds oligo2 Complex
The data accumulated to date show that ds oligo2 and ERE interact with ER differently. To determine whether accessory proteins were participating in the establishment of the oligo2-ER complex, we determined the size of the ER-oligo2 complex according to the method of Ferguson (35) . Samples were run in gels of different polyacrylamide concentrations (T%) along with M r markers, as described in Materials and Methods. The larger the protein size, the more pronounced was the decrease in protein mobility due to the increasing sieving of the polyacrylamide matrix. The log 10 of protein mobility was plotted against the corresponding gel concentrations, and the slope of the resulting straight line, defined as K R , was computed. The molecular size of the test sample, inversely proportional to K R , may be estimated by comparing its mobility to that of a series of standards (Fig. 8) . In untransfected COS-1 cells no retarded band could be observed (Fig. 8, middle section) . With extracts from ER-COS and MCF-7, the size of the ERds ERE complex was evaluated at 158 kDa, whereas that of the ER-ds oligo2 complex corresponded to 143 kDa (Fig. 8B) . The difference in size between the two complexes is accounted for by the different lengths of the two test oligonucleotides (33 nucleotides for ds ERE vs. 18 nucleotides for ds oligo2 ).
These figures, therefore, indicate that both oligonucleotides bound either the dimeric form of the activated ER or its monomeric form plus an accessory protein with a M r around 67 kDa; no sign of different migrations of the complexes from the two cell lines could be detected.
DISCUSSION
The present study stems from the observation of a paradoxical increase in ER content in MCF-7 cells treated with oligonucleotides aimed at blocking ER mRNA translation. Our results are in agreement with those of a previous study by Williard et al. (36) , in which ER activity was demonstrated to be significantly increased in cells expressing antisense ER RNA.
It could be hypothesized that the effects observed in the presence of oligonucleotides are linked to the mechanism of ER autologous down-regulation, which, according to Kaneko et al. (20) and Burnstein et al. (21) , occurs via a transcriptional repression exerted by estrogen (or glucocorticoid) receptors on the ER (or glucocorticoid receptor) genes. This effect would be mediated by specific DNA sequences, acting similarly to the negative response elements well characterized for glucocorticoid and thyroid hormone receptors (37) . In this perspective, the oligos we describe would compete with the target gene for ER, thereby decreasing the efficacy of ER repression. In agreement with this hypothesis is the finding that ER specifically binds oligos 1 and 6 (data not shown) and oligo2, which are active in determining the receptor up-regulation, and it does not interact with the inactive oligos (oligos 3, 4, and 5). However, a number of other observations argue against the hypothesis of ER acting as a repressor: 1) the oligos determining ER up-regulation have a sequence quite dissimilar from one another and certainly very different from any ERE described to date; 2) autologous down-regulation of the ER was observed with the ER mutant C241A/C244A, which is transcriptionally inactive; 3) the activity of a reporter gene controlled by a promoter containing oligo2 failed to show any negative transcriptional activity of ER. Indeed, the transcription from this promoter was slightly increased in the presence of ER and was hormone independent. ER, therefore, seems to modulate the transcription of its own gene via an alternative mechanism.
The gel shift analysis carried out under denaturing and nondenaturing conditions suggests that ER interacts differently with oligo2 and ERE. The migration across the urea gradient clearly shows that the binding to ds oligo2 prevents the change in ER conformation observed at about 0.5 M urea with the ER-ERE complex. In addition, ERE competes for binding to the receptor with all forms of oligo2, while the opposite does not apply to oligo2, even for very high concentration ratios (up to a 10,000-fold molar excess; data not shown). It is, therefore, conceivable that oligo2 and ERE do not bind the same ER domain; however, the binding to ERE hinders the oligo2-binding site.
On the basis of what we described above, it could be proposed that autologous down-regulation of ER occurs via a novel mechanism of receptor-DNA interaction that is unrelated to the mechanism of hormonedependent transcriptional repression. This is further supported by the fact that full antagonists of the ER receptor, such as ICI 182,780, which allows the formation of transcriptionally unproductive ER-ERE complexes, are extremely efficient in causing ER downregulation (38, 39) .
The fact that ER uses two different mechanisms of DNA interaction to induce the transcription of target genes and the repression of its own is not totally surprising. It is quite possible that, once activated by the cognate hormone, ER binds the responsive elements to modulate the transcription of the target genes, which are then inactivated by still undescribed modifications. In this transcriptionally inactive form, however, the receptor could acquire the capability to interact, directly or via specific adapter proteins, with its own gene to hinder its own transcription. Supporting this view is the observation that the phenomenon of down-regulation requires a longer time than transcription to start. Our study did not allow us to prove that accessory proteins take part in binding of the ER to oligo2; in the migration study performed according to the method of Ferguson (35) , no distinguishable difference in size for the complexes ER-oligo2 and ER-ERE was observed regardless of the ER protein source (MCF-7 or COS-1 transfected with ER). We hypothesize, therefore, that a homodimer of the receptor is responsible for binding the ER gene; however, we cannot rule out the hypothesis that in the complex with oligo2, ER heterodimerizes with a protein with a M r very close to 67 kDa. Other reports on steroid receptors (estrogen or progesterone) suggest that they can modulate transcriptional events in a conformation that does not require the presence of the DNAbinding domain (40, 41) .
A better understanding of this phenomenon might have important pharmacological consequences, as certain drugs could be devised to induce the specific conformation aimed at carrying out a selected task.
The squelching assay with short oligonucleotide sequences homologous to the 5Ј-segment of the ER gene here described can be used to identify the targets of ER in autologous regulation and might be relevant for clarification of the mechanism of ER activity.
MATERIALS AND METHODS
Chemicals
Oligodeoxynucleotides were synthesized by Pharmacia Biotech (Cambridge, UK). E 2 was purchased from Sigma Chemical Co. (St. Louis, MO). Cell culture reagents were obtained from Flow Laboratories (Irvine, Scotland), Merck (Darmstadt, Germany), and Life Technologies (Madison, WI). All other reagents were molecular biology grade from Boehringer Mannheim (Mannheim, Germany) and Merck unless otherwise specified. Plasticware was obtained from Corning (Corning, NY). RPMI 1640 and DMEM were purchased from Sigma and Life Technologies (Paisely, UK), respectively. FBS was obtained from Imperial (Unipath, UK). The expression vector containing the human ER cDNA was provided by G. Greene (University of Chicago, Chicago, IL) (42) . The pUHC-␤-galactosidase (pUHC-␤gal) was obtained from Promega. ER mutants (38) were a gift from M. Parker.
Cell Culture
MCF-7 and COS-1 cells were grown in RPMI 1640 without phenol red (Sigma, Milan, Italy) supplemented with 10% charcoal-stripped FBS (DCC-FBS) (43) . The cells were grown in 100-mm petri dishes containing 10 ml culture medium. About 1 ϫ 10 6 cells were seeded/dish. The medium was replaced every 4 days. Once a week, at semiconfluence, the cells were split by treatment with trypsin (0.5 g/liter trypsin and 0.2 g/liter EDTA) for 5 min at 37 C and resuspension in fresh medium at a 1:20 dilution.
To test aODN activity, the cells were plated in 2.5-cm wells (0.3 ϫ 10 6 cell/well) and grown in phenol red-free medium supplemented with 10% DCC-FBS. To limit the degradation of the oligonucleotides by serum nucleases, the FBS was heat inactivated at 65 C for 45 min (44) . As some degradation still occurred, as evaluated by PAGE, 14 M nucleotides, dissolved in water, were added every 24 h. MCF-7 cells were treated in parallel with several oligonucleotides for 48 h. E 2 was diluted in phenol red-free RPMI at a final concentration of 10 Ϫ8 M/0.01% ethanol; 0.01% ethanol was added to controls. ER quantitation was performed in duplicate on high salt buffer extracts as previously described (26) . ER content was quantified immunoenzymatically (ER-EIA kit, Abbott Laboratory, North Chicago, IL) and normalized for the protein concentration, as evaluated by Bradford's method (45) .
Transient Transfection Assay
E2-Induced Down-Regulation in COS Cells
Transfected with ER Twenty-four hours before transfection, 2 ϫ 10 5 cells were plated in 2.5-cm wells containing 3 ml phenol red-free RPMI 1640 medium supplemented with 10% DCC-FBS. Six hours before addition of the CaPO 4 -DNA mixture, the medium was replaced with DMEM with 10% DCC-FBS containing 1 nM E 2 or its solvent. In a typical experiment, the cells were transfected using the following DNA concentrations: 200 l of a suspension of 0.05 mg/ml ER cDNA (or its mutants), 0.05 mg/ml of the gene pUHC-␤gal (as control for transfection efficiency), and 0.12 mg/ml carrier DNA (pGEM3z) in 1.8 ml medium. Sixteen hours after addition of the precipitate, the medium was discarded and, after a few washes with RPMI 1640, replaced with phenol red-free RPMI 1640 containing 1% DCC-FBS (with or without E 2 ). Fortyeight hours later, the medium was removed, the cells were washed several times with PBS, and cell extracts were prepared according to the method of Patrone et al. (46) . ␤Gal activity was measured as previously reported (47) . The protein content was measured according to the method of Brad-MOL ENDO · 1997 Vol 11 No. 7 ford (45) . Each experiment was repeated at least three times on duplicate samples.
Assessment of ER Transactivation Activity of oligo2-pGL2B
For plasmid construction, the oligo2-pGL2B-luciferase reporter was generated by insertion of ds oligo2 into the SmaI site of the pGL2B plasmid (Promega). Transfections Cells were plated at high density, as described above (HeLa cells were grown in Modified Eagle's Medium). Cells were transfected with 1.5 g oligo2-pGL2B-luciferase (or pGL2B-luciferase), 0.5 g pCMV-␤gal, and 1 g ER expression plasmid or mock plasmid. All transfections were performed in triplicate. After a 2-h transfection, the cells were washed, and fresh medium containing either 1 nM E 2 or its solvent was added. After 48-h incubation, luciferase and ␤gal were measured as previously described (48) .
Gel Retardation Assay
The EMSA was performed as described by Bettini et al. (49) . The entire incubation mixture (10 l) was loaded onto nondenaturing polyacrylamide gels (6% T and 2.5% C). The gels were run with TBE buffer (90 mM Tris-HCl, 90 mM boric acid, and 10 mM EDTA) for about 2 h. Gels were then dried with a gel dryer (Slab Dryer, Savant, Holbrook, NY) and exposed to x-ray film (Kodak RP, Eastman Kodak, Rochester, NY) for about 16 h. The gel retardation analysis was performed on several samples to which the same unlabeled competitor was added in various concentrations (4 nM to 1 M) in the presence of a fixed concentration of [ 32 P]oligo. After densitometric scanning of the autoradiograph, the results were evaluated as homologous competition models by the program Ligand (to calculate the apparent affinity of ER for the DNA) (28) .
Bandshift Assay
The labeled probes (10,000 cpm/lane) were incubated with 2 g MCF-7 nuclear extract in a buffer consisting of 10 mM HEPES (pH 7.9), 100 mM KCl, 1 mM dithiothreitol, 0.5 mM EDTA, 2.5 mM MgCl 2 , 6% glycerol, and 2% Ficoll. The reaction was allowed to proceed at room temperature for 10 min. The addition of the antibody (100 ng) was made before mixing with the labeled probe. The samples were subjected to electrophoresis (150 V at room temperature) in a nondenaturing 5% T polyacrylamide slabs in 0.5 ϫ Tris-borate-EDTA for 4 h.
Electrophoresis across a Transverse Urea Gradient
The complexes between hormone-saturated ER and the four oligonucleotides were run across 0-to 8-M urea gradients according to the method of Creighton (29) . The polyacrylamide matrix had a concentration of 6.5% T and 4% C in TBE buffer. The gels were cast against GelBond PAG foils (FMC, Rockville, MD) in a 0.5-mm thick cassette (18-1013-74, Pharmacia, Uppsala, Sweden); one or two parallel sample application trenches were shaped with 170 ϫ 2.5-mm 2 strips of embossing tape glued to the glass plate. A 4-ml concentration plateau of the 8-M urea mix was poured first, followed by an 8-ml urea gradient delivered from a two-chamber mixer (18-1019-87, Pharmacia) and a further concentration plateau from the solution without urea. The gels were run in a horizontal electrophoresis chamber (Multiphor, LKB Pharmacia). To minimize radioactive contamination, according to the suggestion of Kleine et al. (50) , 1% agarose strips in 4 ϫ TBS (5 ϫ 15 ϫ 250 mm 3 ) were substituted for electrodic solutions and paper wicks. Under a constant voltage of 100 V/11 cm and at a temperature of 15 C, the run of a single sample lasted 80 min. When the behavior of a different oligonucleotide complex was compared with that of ERE, the latter was applied first in the more cathodal trench, whereas the second sample was loaded after a 30-min run, once the free oligonucleotide had migrated past the more anodal trench. The sample volume was 130 l, containing 20 g of nuclear proteins (in 20 l), 75 l EMSA buffer (48), 1 g HaeIII-cut pBR322 (in 1 l), 2 l [ 32 P]oligo to a specific activity of about 10 Ϫ8 dpm/g DNA, and 13 l H 2 O; the mixture was incubated for 30 min at room temperature, then added with 22 l DNA dye [50% (vol/vol) glycerol, 0.25% (wt/vol) bromophenol blue, and 0.25% (wt/vol) xylene cyanol].
The Ferguson Plot
The molecular size of ER-oligonucleotide complexes was evaluated on polyacrylamide gels (4% and 8% T), cast in TBE buffer according to the method of Ferguson (34) . The 250 ϫ 125 ϫ 0.5-mm 3 slabs, supported on GelBond PAG foils, were polymerized in halves at the two gel concentrations. Sample and marker proteins (␣-lactalbumin, carbonic anhydrase, and BSA plus ovalbumin, which, however, exhibited an anomalous behavior in the presence of borate ions; all markers from Sigma Chemical Co., St. Louis, MO) were dissolved in high salt buffer; 7 l were applied/lane, corresponding to 7 g of the markers and 5-8 g of the nuclear proteins. The gels were run at 15 C for 90 min in a Multiphor chamber (Pharmacia) at 100 V/11 cm. The marker proteins were stained with Coomassie blue R, whereas the ER-oligonucleotide complexes were detected by autoradiography.
Western Analysis of the ER Protein
Sample preparation was the same for MCF-7 and COS-1 cells, except that MCF-7 lysates were first subjected to an immunoprecipitation step, as previously reported (51) . Thirty micrograms of proteins were immunoprecipitated, then denatured and loaded onto a 10% SDS-polyacrylamide slab gel. After electrophoretic migration, the proteins were transferred to Hybond-C Extra nitrocellulose (Amersham) in a Trans-Blot apparatus (Bio-Rad, Hercules, CA). Blots were stained with Red Ponceau (Sigma, St. Louis, MO) to assess the efficiency of protein transfer. The filters were saturated for 16 h with 5% milk proteins and 0.2% Tween-20 in TBS (50 mM Tris and 150 mM NaCl) before incubation with the anti-ER monoclonal antibody H 222 (Abbott Laboratories, North Chicago, IL). Immunoreactive proteins were detected after incubation with a peroxidase-conjugated secondary antibody (rabbit anti rat-IgG antibody, Vector Laboratories, Burlingame, CA) through ECL reaction (Amersham) and exposure to Hyperfilm-MP (Amersham).
Semiquantitative Analysis of ER mRNA by reverse transcription-PCR
Total cell RNA was isolated with the Bio/RNA-X Cell kit (Bio/ Gene, Kimbolton Cambs, UK) using 1 ml RNA-X reagent for 5-10 ϫ 10 6 cells. One microgram of RNA was reverse transcribed using oligo(deoxythymidine) 12Ϫ18 and Moloney murine leukemia virus reverse transcriptase (HT Biotechnology, Cambridge, UK) as previously described (46) . One tenth of the reaction of cDNA was amplified in a 100-l mixture con-taining 2.5 U DynaZyme-DNA polymerase (Finenzyme OY, Espo, Finland), the buffer provided by Finenzyme, 0.2 M deoxy-NTP, and 100 pmol PCR primers, the 18-mers 5Ј-AGC GTG TCT CCG AGC CCG-3Ј and 5Ј-TGC ACA GTA GCG AGT CTC-3Ј for human ER. Fifty picomoles of a set of primers for the constitutively expressed enzyme GAPDH (the 24-mers 5Ј-CCA CCC ATG GCA AAT TCC ATG GCA-3Ј and 5Ј-TCT AGA CGG CAG GTC AGG TCC ACC-3Ј) were used in each reaction as an internal control for the amount of mRNA transcribed and amplified. After denaturing at 94 C for 2 min, PCR amplification was performed for 32 cycles (94 C for 15 sec, 48 C for 20 sec, and 72 C for 30 sec), followed by a final extension step (72 C for 3 min). The duration and temperature of the PCR cycles were experimentally optimized to fall into the exponential phase of the amplification (52) .
